Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04975> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04975 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04975 label "Banoxantrone [drugbank:DB04975]" assertion.
- drugbank:DB04975 seeAlso DB04975 assertion.
- drugbank:DB04975 description "Banoxantrone is a highly selective bioreductive drug that is activated in, and is preferentially toxic to, hypoxic cells in tumours. It has been shown to work synergistically with fractionated radiation to significantly delay growth of tumours compared to administration of either banoxantrone or radiation alone. Banoxantrone was also efficacious in tumour models when administered in combination with either cisplatin or chemoradiation. (PMID: 10864207)" assertion.
- drugbank:DB04975 identifier "drugbank:DB04975" assertion.
- drugbank:DB04975 title "Banoxantrone" assertion.
- drugbank:DB04975 drugbank_vocabulary:x-cas cas:136470-65-0 assertion.
- drugbank:DB04975 drugbank_vocabulary:drugbank-id "DB04975" assertion.
- drugbank:DB04975 bio2rdf_vocabulary:x-identifiers.org DB04975 assertion.
- drugbank:DB04975 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04975" assertion.
- drugbank:DB04975 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04975 bio2rdf_vocabulary:identifier "DB04975" assertion.